Effective April 2, 2025, all screeners previously provided by Sivadata Pty Ltd have been transferred to Kalkine Pty Ltd, a related entity of Sivadata Pty Ltd. You can access these screeners via the link https://kalkine.com.au/screeners.
Stock Market

Capital One stock surges after Discover Financial deal approved

Investing | Mon, Apr 21 2025 09:51 PM AEST

1695367561_650d4189d32c8_1692951951_64e8658fe70f4_breaking_news_600.png
Image Source: Sivastatz
Capital One stock surges after Discover Financial deal approved

Investing.com -- Capital One shares are up premarket Monday after U.S. regulators approved the bank’s $35 billion acquisition of Discover Financial.

The stock is trading 3.8% higher following the decision from the Federal Reserve and the Office of the Comptroller of the Currency.

The deal, now cleared to close on May 18, will give Capital One (NYSE:COF) control of Discover’s payment network and provide long-term strategic benefits, according to analysts.

“We view the deal as a positive for COF bringing long-term strategic benefits while also being attractive from a financial standpoint,” Bank of America (NYSE:BAC) wrote in a note to clients, maintaining a Buy rating on the stock.

Wells Fargo (NYSE:WFC) added that the approval “should support multiple expansion and 15%+ EPS accretion in '27,” with the merger giving Capital One “a global payment network” and the potential to “expand into areas 'beyond banking.’”

The move also sets the stage for broader bank consolidation. “Investors believe approval of the COF/DFS deal will kick off further bank M&A,” Wells Fargo wrote.

The firm added that the deal reflects “a down payment on the improved regulatory environment from the new administration.”

Discover, meanwhile, will pay $1.2 billion in restitution to affected merchants and $250 million in fines tied to years-long card misclassification practices.

However, Bank of America noted that Discover “has already reserved for these fines / restitution so the earnings impact should be limited.”

This article first appeared in Investing.com

Market Updates

Ferring Announces Initial Data from Phase 3 Trial in Japanese Patients Demonstrating 75% Complete Response Rate at 3 Months with (nadofaragene firadenovec) in BCG-unresponsive NMIBC Patients1

First results from a Phase 3 trial conducted across 25 centers in Japan were presented at the Annual Meeting of the Japanese ...

Business Wire | Tue, Apr 22 2025 03:30 AM AEST

Read More
Market Updates

Novotech Identifies Strategic Opportunities in Idiopathic Pulmonary Fibrosis Trials with Release of Global Market Insights

SYDNEY--(BUSINESS WIRE)--#IPFResearch--Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and ...

Business Wire | Tue, Apr 22 2025 01:05 AM AEST

Read More
Stock Market

TD Cowen downgrades Global Payments saying Worldpay deal muddies turnaround story

Investing.com -- TD Cowen downgraded Global Payments (NYSE:GPN) Inc. to Hold from Buy and slashed its price target ...

Investing | Tue, Apr 22 2025 12:39 AM AEST

Read More
Stock Market

Salesforce core business neglected on AI pivot, DA Davidson says downgrading co

Investing.com -- DA Davidson downgraded Salesforce.com (NYSE:CRM) to Underperform from Neutral, saying the company is prioritizing its ...

Investing | Tue, Apr 22 2025 12:01 AM AEST

Read More
World News

SPOTLIGHT: Nielsen Study Connects Culture With the Bottom Line

Originally published on Geena Davis InstituteA new study from Nielsen, which arrives just in time for Black History Month, serves ...

3BL | Tue, Apr 22 2025 12:00 AM AEST

Read More